Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot, Multicenter, Single Arm, Open Label, Surgical Window of Opportunity Study of Abemaciclib and Letrozole for Endometrioid Adenocarcinoma of the Endometrium

NCT04049227 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04049227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04049227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot, Multicenter, Single Arm, Open Label, Surgical Window of Opportunity Study of Abemaciclib and Letrozole for Endometrioid Adenocarcinoma of the Endometrium
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Completed
Start date
August 12, 2019
Completion date
May 15, 2023
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial endometrioid adenocarcinoma